熱點掃描 | 生物技術股強勢反彈，金斯瑞漲超7%
uSMART盈立智投8月13日消息，截止發稿，恆指跌0.43%，報26406.50點，成交額超435億，國企指數跌0.75%，恆生科技指數跌1.72%，港股通淨流出4.53億。
生物技術股強勢反彈，截止10:40，金斯瑞生物漲超7%，諾誠建華漲近6%，百濟神州漲超4%，泰格醫藥、騰盛博藥、科濟藥業均漲超3%，康諾亞、康方生物、藥明康德均漲超2%，其中藥明康德上半年歸母淨利26.75億元 同比增長55.8%。
紙業股走高，截止10:40，玖龍紙業漲超4%，晨鳴紙業、陽光紙業漲超2%，理文造紙漲超1%。紙業被機構唱好，此前大和升理文造紙目標價11%，花旗升理文目標價至8.6元。
電信股走強，截止10:40，中國移動漲超3%，移動上半年營收同比增13.8%，歸母淨利潤同比增6%，創近10年最大增幅；中國聯通、中國電信均漲超1%。
大型科技股普遍下挫，截止10:40，衆安在線繼續下跌超4%，汽車之家跌超3%，騰訊、阿裏、百度、小米均跌超2%，網易、聯想、金山軟件均跌超1%，美團跌幅不足1%；萬國數據逆勢大漲近5%，舜宇漲超2%，蘋果分析師強調iPhone在中國市場的需求強勁反彈；京東、b站漲幅均不足1%。
半導體板塊承壓，截止10:40，華虹半導體超4%，已是連續第五日下挫，距高位回調超20%，公司昨日午間公佈中期業績，純利同比增102.3%至7714.1萬美元；中芯國際、上海復旦跌超2%，晶門半導體跌超1%。
短視頻概念股走弱，截止10:40，中國有贊跌3%，快手、微盟跌超2%，映客、樂享集團跌超1%。
個股方面，截止10:40，中國黃金國際漲超12%，中期淨利潤同比增加1493%至1.577億美元；光大環境再漲超8%，中期純利同比增長28%至38.87億港元；易大宗,績後漲超26%，預期中期純利不少於6億港元 主因煤炭市場需求旺盛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
